These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 520078)

  • 21. A review of the drug events reported by 12,917 patients treated with cephalexin.
    Burt RA
    Postgrad Med J; 1983; 59 Suppl 5():47-53. PubMed ID: 6364090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study of S-6437 in pediatrics (author's transl)].
    Minamitani M; Hachimori K; Nakazawa H
    Jpn J Antibiot; 1977 Sep; 30(9):677-83. PubMed ID: 916188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, comparative study of oral cefadroxil and cephalexin in lower respiratory infections in adults.
    Weingarten C
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():109-13. PubMed ID: 7142086
    [No Abstract]   [Full Text] [Related]  

  • 24. Cephalexin concentrations in sputum during acute respiratory infections.
    Halprin GM; McMahon SM
    Antimicrob Agents Chemother; 1973 Jun; 3(6):703-7. PubMed ID: 4790621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Trial of use of a new oral antibiotic: cephalexin in granules in 59 children].
    Bovier-Lapierre M; David M; Lauras B
    Lyon Med; 1971 Dec; 226(20):895-900. PubMed ID: 5144397
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical results with cefadroxil (BL-S578) for respiratory infections (author's transl)].
    Suzuki H; Kunieda T; Osakabe Y; Nakagami K; Satomi T; Saruta E; Noguchi E
    Jpn J Antibiot; 1980 Mar; 33(3):354-7. PubMed ID: 7401308
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative study of the efficacy of co-trimoxazole and cephalexin in respiratory infections.
    Phadtare JM; Rangnekar RY
    Pharmatherapeutica; 1988; 5(3):183-8. PubMed ID: 3258993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect and adverse effects of cephalexin in complicated urinary tract infections].
    Holm SE; Wentzel T
    Lakartidningen; 1977 Apr; 74(17):1723-48 1726. PubMed ID: 853810
    [No Abstract]   [Full Text] [Related]  

  • 29. [Fundamental and clinical studies on S-6436 (author's transl)].
    Nasu M; Nakatomi M; Hirota M; Nagasawa T; Horiuchi N
    Kansenshogaku Zasshi; 1977 Jul; 51(7):371-6. PubMed ID: 411852
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical experience of cefadroxil for respiratory infections (author's transl)].
    Kajiki A; Takamoto M; Ishibashi T
    Jpn J Antibiot; 1980 Dec; 33(12):1274-6. PubMed ID: 7241800
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experience with sustained release cephalexin (S-6437) in pediatrics (author's transl)].
    Hori M; Okamoto K; Kohno S
    Jpn J Antibiot; 1978 Feb; 31(2):59-71. PubMed ID: 642208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of BL-S578 for respiratory infections (author's transl)].
    Sowa K
    Jpn J Antibiot; 1980 Mar; 33(3):358-60. PubMed ID: 7401309
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cefadroxil therapy of respiratory infections in childhood].
    Baldini G; Barretta G; Cantergiani R; Soldateschi M
    Minerva Pediatr; 1983 May; 35(9):463-6. PubMed ID: 6877204
    [No Abstract]   [Full Text] [Related]  

  • 34. A multicenter comparison of related pharmacologic features of cephalexin and dicloxacillin given for two months to young children with cystic fibrosis.
    Harrison CJ; Marks MI; Welch DF; Sharma BB; Baker D; Dice J
    Pediatr Pharmacol (New York); 1985; 5(1):7-16. PubMed ID: 3921934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of S-6437 in pediatrics regarding clinical efficacy, blood levels and urinary excretion (author's transl)].
    Nanri S; Sunagawa K; Hara N; Kimura K; Osano M
    Jpn J Antibiot; 1977 Sep; 30(9):699-709. PubMed ID: 916191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy of cefadroxil in acute and chronic bacterial infections of the respiratory tract].
    Nosenzo M; Razzetti A; Delle Piane M; Faravelli B; Suffritti G
    Clin Ter; 1983 Mar; 104(5):383-9. PubMed ID: 6342913
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sustained release cephalexin (S-6436) and genitourinary tract infection (author's transl)].
    Furusawa T; Tanaka S
    Jpn J Antibiot; 1977 Oct; 30(10):806-18. PubMed ID: 592483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of S-6437 (sustained release cephalexin) in pediatrics (author's transl)].
    Iwai N; Suzuki C; Maki T; Tauchi N; Kawamura M
    Jpn J Antibiot; 1977 Sep; 30(9):710-21. PubMed ID: 916192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cephalexin in pulmonary infections in children].
    Paschetta G; De Biasi V
    Minerva Pediatr; 1971 Dec; 23(49):2065-71. PubMed ID: 5131194
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of pulmonary infections with cephalexin (author's transl)].
    Götz M; Klabuschnigg A
    Padiatr Padol; 1978; 13(2):221-5. PubMed ID: 643299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.